Related Experiment Video

Updated: Jul 13, 2026

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
10:01

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

Published on: March 31, 2022

Are one or two dangerous? Calcium channel blocker exposure in toddlers

Claudia Ranniger1, Colleen Roche

  • 1Department of Emergency Medicine, George Washington University, Washington, DC, USA.

The Journal of Emergency Medicine
|August 19, 2007
PubMed

Insights

Unintentional pediatric ingestions of calcium channel blockers (CCBs) can cause severe symptoms, even death, in children under 6. Emergency evaluation and observation are crucial following any CCB ingestion in this age group.

Area of Science:

  • Pediatric Toxicology
  • Cardiovascular Pharmacology
  • Emergency Medicine

Background:

  • Pediatric ingestions of calcium channel blockers (CCBs) are rising due to increased antihypertensive use.
  • The precise toxicity of low-dose CCB ingestions in young children is not well-established.
  • Severe outcomes like refractory hypotension and death are potential risks.

Purpose of the Study:

  • To review existing literature on CCB toxicity in children under 6 years of age.
  • To define toxic and lethal dosages for pediatric CCB ingestions.
  • To establish guidelines for managing unintentional pediatric CCB ingestions.

Main Methods:

  • A comprehensive literature review was performed.
  • Studies focusing on pediatric populations under 6 years of age were analyzed.
  • Data on symptomatic ingestions, toxic dosages, and outcomes were extracted.

Main Results:

  • Most accidental pediatric CCB ingestions are asymptomatic.
  • A small subset of ingestions lead to significant cardiovascular instability or fatalities.
  • Dihydropyridines (e.g., nifedipine) and verapamil are most frequently associated with symptomatic ingestions.
  • Ingestion of a single pill has been documented to cause severe symptoms, including death.

Conclusions:

  • Emergency evaluation is essential for all pediatric CCB ingestions.
  • Gastrointestinal decontamination and extended in-hospital observation are recommended.
  • Observation periods should be at least 6 hours for regular-release and 12-24 hours for sustained-release CCBs.

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...